Societe de Therapeutique Marocaine S.A. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was MAD 1,184.47 million compared to MAD 1,150.23 million a year ago. Net income was MAD 152.05 million compared to MAD 158.28 million a year ago.

Basic earnings per share from continuing operations was MAD 21.1 compared to MAD 22 a year ago. Diluted earnings per share from continuing operations was MAD 21.1 compared to MAD 22 a year ago.